HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory N Fuller Selected Research

Purinergic P1 Receptors (Adenosine Receptor)

1/2020Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory N Fuller Research Topics

Disease

87Neoplasms (Cancer)
02/2024 - 01/2002
64Glioma (Gliomas)
12/2023 - 01/2002
35Glioblastoma (Glioblastoma Multiforme)
12/2023 - 01/2002
10Astrocytoma (Pilocytic Astrocytoma)
02/2024 - 01/2002
8Brain Neoplasms (Brain Tumor)
05/2024 - 03/2002
7Breast Neoplasms (Breast Cancer)
12/2023 - 03/2004
7Carcinogenesis
01/2020 - 12/2008
6Medulloblastoma
01/2021 - 03/2002
6Neoplasm Metastasis (Metastasis)
09/2018 - 03/2004
6Melanoma (Melanoma, Malignant)
07/2012 - 11/2003
5Necrosis
09/2018 - 07/2002
5Oligodendroglioma
11/2011 - 01/2002
4Disease Progression
01/2022 - 07/2003
3Ganglioneuroma
01/2020 - 06/2002
3Hypoxia (Hypoxemia)
01/2016 - 07/2002
3Neurocytoma
01/2016 - 01/2004
3Infections
12/2014 - 10/2003
2Carcinoma (Carcinomatosis)
01/2023 - 05/2008
2Gliosis
01/2020 - 10/2002
2Renal Cell Carcinoma (Grawitz Tumor)
10/2018 - 09/2018
2von Hippel-Lindau Disease (von Hippel Lindau Disease)
10/2018 - 05/2018
2Chordoma
03/2018 - 10/2016
2Adenoma (Adenomas)
05/2010 - 02/2005
2Paraganglioma (Paragangliomas)
05/2008 - 01/2004
2Cysts
01/2008 - 11/2005
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2005 - 09/2004
1Choriocarcinoma
01/2024
1Lung Neoplasms (Lung Cancer)
01/2024
1Phyllodes Tumor (Cystosarcoma Phylloides)
12/2023
1Acoustic Neuroma (Acoustic Neurinoma)
10/2022
1Choroid Plexus Neoplasms (Choroid Plexus Tumor)
02/2022
1Choroid Plexus Papilloma
02/2022
1Choroid Plexus Carcinoma
02/2022

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2002
12Insulin-Like Growth Factor Binding Protein 2IBA
01/2016 - 01/2002
10Biomarkers (Surrogate Marker)IBA
06/2019 - 01/2009
7RNA (Ribonucleic Acid)IBA
01/2023 - 02/2013
7MicroRNAs (MicroRNA)IBA
12/2018 - 02/2013
7STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2016 - 12/2008
7Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
05/2015 - 07/2007
6Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
02/2024 - 08/2012
6Platelet-Derived Growth FactorIBA
05/2015 - 04/2005
5WP1066IBA
01/2022 - 09/2008
5Therapeutic UsesIBA
01/2020 - 07/2013
5AntigensIBA
01/2020 - 06/2007
5Messenger RNA (mRNA)IBA
12/2018 - 01/2004
4Phosphotransferases (Kinase)IBA
06/2019 - 09/2004
4IntegrinsIBA
01/2019 - 05/2003
4Transcription Factors (Transcription Factor)IBA
03/2018 - 03/2002
4ParaffinIBA
03/2018 - 12/2002
4Hematoxylin (Haematoxylon)IBA
11/2017 - 05/2015
4Eosine Yellowish-(YS) (Eosin)IBA
11/2017 - 05/2015
4Protein Isoforms (Isoforms)IBA
05/2015 - 05/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 03/2002
4Complementary DNA (cDNA)IBA
05/2006 - 01/2002
3ErbB Receptors (EGF Receptor)IBA
12/2023 - 08/2004
3Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 01/2019
3ChromatinIBA
11/2018 - 11/2011
3Carrier Proteins (Binding Protein)IBA
11/2018 - 01/2002
3Histones (Histone)IBA
05/2015 - 11/2011
3Insulin-Like Growth Factor Binding ProteinsIBA
02/2012 - 05/2006
3Hormones (Hormone)IBA
01/2009 - 02/2005
2Carboplatin (JM8)FDA LinkGeneric
01/2024 - 07/2008
2epidermal growth factor receptor VIIIIBA
12/2023 - 12/2014
2Doxycycline (Periostat)FDA LinkGeneric
01/2023 - 01/2016
2CytokinesIBA
01/2020 - 12/2014
2Programmed Cell Death 1 ReceptorIBA
01/2020 - 10/2016
2ChemokinesIBA
01/2019 - 12/2014
2Dexamethasone (Maxidex)FDA LinkGeneric
12/2018 - 05/2008
2Formaldehyde (Formol)FDA Link
03/2018 - 11/2003
2Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2018 - 01/2004
2SurvivinIBA
02/2017 - 09/2014
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2016 - 08/2004
2TensinsIBA
10/2016 - 08/2004
2Progesterone Receptors (Progesterone Receptor)IBA
01/2016 - 05/2008
2Glial Fibrillary Acidic ProteinIBA
01/2016 - 10/2002
2S100 Proteins (S 100 Protein)IBA
01/2016 - 05/2010
2Cyclin D1IBA
05/2015 - 03/2004
2LigandsIBA
01/2011 - 07/2010
2NestinIBA
12/2010 - 10/2002
2Integrin alpha5IBA
07/2010 - 05/2006
2Fibronectins (Fibronectin)IBA
07/2010 - 03/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2009 - 01/2009
2Estrogen ReceptorsIBA
05/2008 - 01/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2006 - 03/2002
2CollagenIBA
12/2006 - 07/2004
2Retinoblastoma ProteinIBA
05/2006 - 05/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2004 - 07/2002
1Etoposide (VP 16)FDA LinkGeneric
01/2024
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
02/2022
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
02/2022
1cytidylyl-(3'-5')-cytidine (CpC)IBA
02/2022
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2020
1Irinotecan (Camptosar)FDA LinkGeneric
01/2020
1Vincristine (Oncovin)FDA LinkGeneric
01/2020

Therapy/Procedure

28Therapeutics
05/2024 - 01/2002
12Radiotherapy
01/2024 - 01/2003
9Drug Therapy (Chemotherapy)
02/2022 - 01/2002
5Immunotherapy
10/2022 - 06/2007
1Adjuvant Chemotherapy
02/2022